Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease | Molecular Neuroscience
Small molecule BACE1 inhibitors in clinical trials | Download Table
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Semantic Scholar
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein - ScienceDirect
Merck BACE1 drug fails in prodromal Alzheimer's phase 3 | Fierce Biotech
A Close Look at BACE1 Inhibitors for Alzheimer's Disease Treatment. - Abstract - Europe PMC
Frontiers | Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment | Chemistry
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Semantic Scholar
BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease - Chemical Society Reviews (RSC Publishing)
Alzheimer's Disease Insight Report: Current Therapies, Drug Pipeline and Outlook
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Alzheimer's Research & Therapy | Full Text
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Semantic Scholar
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease | Nature Reviews Neurology
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Alzheimer's Research & Therapy | Full Text
IJMS | Free Full-Text | Natural Products Targeting Amyloid Beta in Alzheimer's Disease | HTML
Why BACE inhibitors may be failing Alzheimer' | EurekAlert!
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease* - Journal of Biological Chemistry
The β-Secretase BACE1 in Alzheimer's Disease - Biological Psychiatry
Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment - ScienceDirect
Alzheimer's disease: clinical trials and drug development - The Lancet Neurology
A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease | EMBO Molecular Medicine
Targeting the β secretase BACE1 for Alzheimer's disease therapy - The Lancet Neurology
A Perspective on Multi-target Drugs for Alzheimer's Disease: Trends in Pharmacological Sciences
Frontiers | Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment | Chemistry
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease - Moussa‐Pacha - 2020 - Medicinal Research Reviews - Wiley Online Library
PDF) BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
